Press Releases
November 25, 2020
Surface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx Conference
November 13, 2020
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 11, 2020
Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer
November 10, 2020
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2020
November 9, 2020
Surface Oncology to Present at the Cowen IO Next Summit
November 9, 2020
Surface Oncology to Present SRF388 and SRF114 Preclinical Data at the Upcoming Society for Immunotherapy for Cancer 2020 Virtual Conference
October 26, 2020
Surface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Society’s Cytokines 2020 Virtual Conference
September 16, 2020
Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 11, 2020
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
September 9, 2020
Surface Oncology to Present at the Baird Global Healthcare Conference
Displaying 1 - 10 of 24